Mesenchymal Cells are a versatile and multipotent type of stem cell found in various tissues throughout the body, primarily in the embryonic mesoderm and adult connective tissues. These cells play a crucial role in tissue development, repair, and regeneration. Mesenchymal stem cells (MSCs) are characterized by their ability to differentiate into multiple cell types, including bone, cartilage, adipose tissue, and muscle cells. MSCs exhibit immunomodulatory properties, influencing the immune response and reducing inflammation, making them promising candidates for regenerative medicine and cell-based therapies. In addition to their regenerative potential, mesenchymal cells contribute to tissue homeostasis by secreting bioactive molecules that support cell survival, proliferation, and tissue repair. The regenerative capacity and immunomodulatory features of mesenchymal cells make them valuable in treating various conditions, including musculoskeletal disorders, autoimmune diseases, and injuries. However, research continues to explore the precise mechanisms underlying their functions, standardizing isolation and culture techniques, and addressing challenges to optimize their therapeutic applications. The field of mesenchymal cell biology holds great promise for advancing regenerative medicine and developing innovative treatments for a range of medical conditions.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy